Skip to Main Content

Paper Details

Effect of metformin versus placebo on metabolic factors in the MA.32 randomized breast cancer trial.
NPJ Breast Cancer
19
2021
BC, C-reactive protein, Genomic DNA, Glucose, HER2, M0 BC, Metformin, SNP, breast cancer, diabetic, hormone, hsCRP, insulin, leptin, metformin, rs11212617, rs11212617 SNP, rs11212617 allele
Author NameAffiliation
Lois ShepherdQueen's University
Dawn L HershmanHerbert Irving Comprehensive Cancer Center, Columbia University Medical Center
Ingrid A MayerVanderbilt University
Daniel ReaCancer Research UK Clinical Trials Unit (CRCTU), Institute of Cancer and Genomic Sciences, University of Birmingham
  • 1 - 4

Datasets

Release 1.2